Traumastem Powder in Treatment of Non-Traumatic Anterior Epistaxis in Emergency Department; a Randomized Clinical Trial A New Treatment of Epistaxis
Archives of Academic Emergency Medicine,
Vol. 8 No. 1 (2020),
7 January 2020
Introduction: Various studies are being conducted because of the value of finding an appropriate medication to control bleeding in patients with epistaxis faster and more conveniently. This study aimed to compare the effect of Traumastem powder with routine tampons in treatment of non-traumatic epistaxis.
Methods: This randomized clinical trial enrolled patients with epistaxis presenting to the emergency departments of two hospitals affiliated to Tabriz University of Medical sciences. Patients were divided into two groups using randomization software (intervention group: 107 patients, control group: 96 patients). Primary outcome variables included bleeding control time and patient satisfaction. Secondary outcome variable was recurrence of bleeding within the first 24 hours after treatment. Visual assessment scoring system was used to assess patient satisfaction.
Results: Epistaxis was controlled in less than 5 minutes in 85 (79.4%) patients in the intervention group and 85 (88.5%) patients in the control group (P=0.058). Patient satisfaction in the intervention group was higher than that of the control group (P<0.05). In the intervention group, 10 patients experienced recurrence of epistaxis within 24 hours of treatment, while 9 patients in the control group experienced recurrence (P= 0.591).
Conclusion: Based on the findings, bleeding control time was similar in the two groups, but patient satisfaction was higher in Traumastem group. It is concluded that Traumastem can conveniently control anterior epistaxis, but it is not successful in cases with severe bleeding.
- Emergency department
- Epistaxis; Emergency Service, Hospital; Treatment Outcome; Patient Satisfaction
How to Cite
Farneti P, Pasquini E, Sciarretta V, Macrì G, Gramellini G, Pirodda A. Comparison of Local Sclerotherapy With Lauromacrogol Versus Nasal Packing in the Treatment of Anterior Epistaxis. Clin Exp Otorhinolaryngol. 2016;9(2):131-5.
Murray S, Mendez A, Hopkins A, El-Hakim H, Jeffery CC, Côté DWJ. Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial. J Otolaryngol Head Neck Surg. 2018;47(1):3-.
http://www.traumastem.eu Czech Republic Bioster a.s.
Zboril P, Vyslouzil K, Klementa I, Starý L, Skalický P, Růzicka V. Ambulantní excize perianálnich duplikatur [Ambulatory excision of perianal duplicatures]. Rozhl Chir. 2010;89(12):774-9.
Granville-Chapman J, Jacobs N, Midwinter MJ. Pre-hospital haemostatic dressings: a systematic review. Injury. 2011;42(5):447-59.
Zou Y, Deng YQ, Xiao CW, Kong YG, Xu Y, Tao ZZ, et al. Comparison of outcomes between endoscopic surgery and conventional nasal packing for epistaxis in the posterior fornix of the inferior nasal meatus. Pakistan journal of medical sciences. 2015;31(6):1361-5.
Zahed R, Moharamzadeh P, Alizadeharasi S, Ghasemi A, Saeedi M. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial. The American journal of emergency medicine. 2013;31(9):1389-92.
Ala A, Rahmani F, Shirzadegan S, Ebrahimi Bakhtavar H, Mehdizadeh Esfanjani R. Non - traumatic Epistaxis Management Using Celox® Dressing: A Randomized Clinical Trial. Iran Red Crescent Med J. 2018;20(4):e58374.
McGinnis HD. Nose and Sinuses. In: Tintinalli JE, editor. Tintinalli’s Emergency Medicine. 9 ed. China: Mc Graw Hill; 2020. p. 1572-9.
Sarhan NA, Algamal AM. Relationship between epistaxis and hypertension: A cause and effect or coincidence? J Saudi Heart Assoc. 2015;27(2):79-84.
Alyahya K, Alsaad S, Alsuliman S, Alsuliman N. Awareness about first aid management of epistaxis among medical students in Kingdom of Saudi Arabia. J Family Med Prim Care. 2019;8(3):914-8.
Newton E, Lasso A, Petrcich W, Kilty SJ. An outcomes analysis of anterior epistaxis management in the emergency department. J Otolaryngol Head Neck Surg. 2016;45:24-.
Bachelet JT, Bourlet J, Gleizal A. Hemostatic absorbable gel matrix for severe post-traumatic epistaxis. Rev stomatol Chir Maxillofac Chir Orale. 2013;114:310-4.
Toner JG, Walby AP. Comparison of electro and chemical cautery in the treatment of anterior epistaxis. J Laryngol Otol. 1990;104:617-.
Hutchinson RW, Werrlein S, Johns DB, Zhang G, Clymer JW, Kocharian R. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model. Surgical technology international. 2015;27:53-7.
MacDonald MH, Wang AY, Clymer JW, Hutchinson RW, Kocharian R. An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models. Medical devices (Auckland, NZ). 2017;10:273-9.
Martyn D, Meckley LM, Miyasato G, Lim S, Riebman JB, Kocharian R, et al. Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats. Clinicoecon Outcomes Res. 2015;7:567-74.
Rembe J-D, Böhm JK, Fromm-Dornieden C, Schäfer N, Maegele M, Fröhlich M, et al. Comparison of hemostatic dressings for superficial wounds using a new spectrophotometric coagulation assay. J Transl Med. 2015;13:375-.
Wright JD, Ananth CV, Lewin SN, Burke WM, Siddiq Z, Neugut AI, et al. Patterns of use of hemostatic agents in patients undergoing major surgery. J Surg Res. 2014;186(1):458-66.
- Abstract Viewed: 27 times
- pdf Downloaded: 11 times